Josef H Von Rickenbach
CIK 1007706 · Chairman & CEO · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PRXL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WALTHAM, MA 02451-1163
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RNTX | Director | 58,014 | $0.60 | $34.9K | $49.6K | 2 | 2026-05-28 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | 22,273 | $2.11 | $47.0K | $400.3K | 13 | 2024-12-06 |
| Virgin Orbit Holdings, Inc. (VORBW) Delisted | 125,000 | $0.01 | $875 | $0 | 1 | 2022-01-03 | |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Chairman & CEO | 503,329 | — | — | -$28.55M | 85 | 2017-09-18 |
Recent Filings · Page 5 of 11
102 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-06-11 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | +17,330 | -$215.8K | EDGAR |
| 2012-02-21 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | +8,356 | -$98.6K | EDGAR |
| 2011-12-28 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | +27,565 | -$406.8K | EDGAR |
| 2011-09-23 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Grant (A) | +75,500 | $0 | EDGAR |
| 2011-09-13 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Tax (F) | −14,764 | -$302.7K | EDGAR |
| 2010-09-17 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Grant (A) | +67,800 | $0 | EDGAR |
| 2009-09-11 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Grant (A) | +86,700 | $0 | EDGAR |
| 2009-07-13 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Tax (F) | −60,955 | -$539.5K | EDGAR |
| 2009-05-29 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | +24,226 | $100.4K | EDGAR |
| 2008-10-01 | PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Mixed | — | -$90.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.